The CMS has submitted a series of legislative ideas to Congress they say would better coordinate care for people eligible for both Medicare and Medicaid. These beneficiaries tend to be sicker and more expensive to manage.
A bill introduced by Rep. Doris Matsui (D-Calif.) could give hospitals in the 340B program new price protections, according to providers. The proposal could also reverse a more than $1 billion cut to the federal drug discount program.
HHS Secretary Alex Azar slammed the idea of Medicare being allowed to negotiate drug prices, telling senators the idea could backfire and force the agency to pay even higher prices.
The CMS finalized a natural disaster policy for hospitals in the mandatory Comprehensive Care for Joint Replacement Model, in the hopes of not penalizing hospitals if they exceed spending goals due to uncontrollable events.
A new analysis in the New England Journal of Medicine found insurers may not offer a set of new benefits outlined in the Chronic Care Act to avoid chronically ill patients from joining their Medicare Advantage Plans.
Accountable care organizations are failing to meet their promise to save Medicare money, and regulations governing the model need to change, according to senior White House officials.
HHS Secretary Alex Azar said he wants to team up with Congress to overhaul the Medicare wage index, which lawmakers increasingly say is a threat to rural healthcare.
The Trump administration said Medicare funding will end sooner than previously estimated. That's partly because ending the individual mandate will increase Medicare uncompensated-care payments to hospitals.
AMGA board members asked lawmakers to overturn or scale back a CMS policy that allows thousands of physician practices to opt out of MACRA.
The federal government's payments for brand-name drugs in Medicare Part D soared by more than $40 billion despite declining use of the medications.
The CMS is considering covering a brain stimulation therapy device that helps treat depression in patients who don't respond to other treatments. Hospitals could receive up to $30,000 per patient if the agency covers the device.
The CMS said 91% of clinicians eligible for MIPS submitted data by the April 3 deadline. Even with that success, thousands of clinicians will still face reimbursement cuts for failing to meet MIPS requirements.